The placebo tablets are white to off-white
Sponsors
Orexa B.V.
Conditions
Underweightlongitudinal laparotomy
Phase 2
A multi-center, randomized, double blind, placebo-controlled, phase 2 pilot efficacy study to investigate the efficacy of oral lidocaine (ORE-001) in preventing gastrointestinal disturbance/intolerance in patients after longitudinal laparotomy
CompletedCTIS2022-503113-31-01
Start: 2023-12-19End: 2025-06-24Target: 126Updated: 2025-02-12
A placebo controlled, randomized, double-blind, dose titration phase 2, safety and efficacy study of ORE-001 (oral lidocaine) in underweight elderly participants
RecruitingCTIS2024-516958-22-00
Start: 2025-02-17Target: 60Updated: 2025-02-12